Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
View PublicationLast Modified:
2023-12-22
Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects
Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects
View PublicationLast Modified:
2014-03-17
Cholesteryl ester transfer protein inhibitors: From high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
Cholesteryl ester transfer protein inhibitors: From high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
View PublicationLast Modified:
2021-11-20
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: A randomized phase 2 trial (ROSE)
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: A randomized phase 2 trial (ROSE)
View PublicationLast Modified:
2022-08-11
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial (ROSE2)
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial (ROSE2)
View PublicationLast Modified:
2023-05-20
The Evolving Role of Cholesteryl Ester Transfer Protein Inhibition Beyond Cardiovascular Disease
The Evolving Role of Cholesteryl Ester Transfer Protein Inhibition Beyond Cardiovascular Disease
B
View PublicationLast Modified:
2023-10-28